Results 231 to 240 of about 9,655 (274)
Some of the next articles are maybe not open access.

Copeptin

Journal of Cardiovascular Medicine, 2013
Copeptin, the C-terminal part of the prohormone of vasopressin (AVP), is released together with AVP in stoichiometric concentrations reflecting an individual's stress level. Copeptin has come to be regarded as an important marker for identifying high-risk patients and predicting outcomes in a variety of diseases.
Beata, Morawiec, Damian, Kawecki
openaire   +2 more sources

The Emerging Role of Copeptin

Clinical Biochemist Reviews, 2021
Direct measurement of the nonapeptide vasopressin has been limited by analyte instability ex vivo and in vivo rapid degradation, low serum concentrations requiring a sensitive assay and inherent secretory pulsatility. Copeptin is a 39 amino acid glycopeptide cleavage product of vasopressin synthesis with high stability, providing a marker of ...
R, Jalleh, D J, Torpy
openaire   +2 more sources

Copeptin in fluid disorders and stress

Clinica Chimica Acta, 2022
Copeptin, a glycosylated peptide of 39 amino acids, is the C-terminal segment of arginine vasopressin (AVP) precursor peptide, which is consisted of two other fragments, vasopressin and neurophysin Ⅱ. The main physiological functions of AVP are fluid and osmotic balance, cardiovascular homeostasis and regulation of the endocrine stress response ...
Danni, Mu   +5 more
openaire   +2 more sources

Copeptin in Heart Failure

2016
Heart failure (HF) is one of the most common causes of hospitalization and mortality in the modern Western world and an increasing proportion of the population will be affected by HF in the future. Although HF management has improved quality of life and prognosis, mortality remains very high despite therapeutic options. Medical management consists of a
Louise, Balling, Finn, Gustafsson
openaire   +2 more sources

Copeptin: Pathophysiology and potential clinical impact

Advances in Medical Sciences, 2015
Copeptin, a C-terminal part of the precursor pre-provasopressin is a novel biomarker of arginine-vasopressin (AVP) system. Measurements of AVP concentration are not used in clinical practice because of technical difficulties. Copeptin is synthesized in stoichiometric ratio with AVP, hence it reflects vasopressin concentration in human plasma and serum.
Ewelina, Łukaszyk, Jolanta, Małyszko
openaire   +2 more sources

Home - About - Disclaimer - Privacy